Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Willingness to pay for genetic testing for Alzheimer's disease: a measure of personal utility.

Genetic testing and molecular biomarkers - 1 Dec 2011

Kopits Ilona M, Chen Clara, Roberts J Scott, Uhlmann Wendy, Green Robert C

Abstract excerpt

BACKGROUND: The increased availability of genetic tests for common, complex diseases, such as Alzheimer's disease (AD), raises questions about what people are willing to pay for these services. METHODS: We studied willingness-to-pay for genetic testing in a study of AD risk assessment that included APOE genotype disclosure among 276 first-degree relatives of persons with AD. RESULTS: Seventy-one percent reported...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Attitude to Health

Share to Disclosure

Share to Family

Share to Health Care Costs

Share to Health Care Surveys

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 21749214
DOI: 10.1089/gtmb.2011.0028
PMCID: PMC3241735

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Willingness to pay for genetic testing for Alzheimer's disease: a measure of personal utility.PMID 21749214Read ↗

To know or not to know: an update of the literature on the psychological and behavioral impact of genetic testing for Alzheimer disease risk.Semantic proximity Read ↗

Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk.Semantic proximity Read ↗

Public perceptions of presymptomatic testing for Alzheimer disease.Semantic proximity Read ↗

Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: A survey studySemantic proximity Read ↗

Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study.Semantic proximity Read ↗

Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics.Semantic proximity Read ↗

Genetic susceptibility testing for Alzheimer disease: motivation to obtain information and control as precursors to coping with increased risk.Semantic proximity Read ↗

Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease.Semantic proximity Read ↗

Consumer preferences for the predictive genetic test for Alzheimer disease.Semantic proximity Read ↗

Perceptions of familial risk in those seeking a genetic risk assessment for Alzheimer's disease.Semantic proximity Read ↗

The role of test accuracy in predicting acceptance of genetic susceptibility testing for Alzheimer's disease.Semantic proximity Read ↗

Assessing the Psychological Impact of Genetic Susceptibility TestingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.